Literature DB >> 2373368

Primary structure of rat secretory acid phosphatase and comparison to other acid phosphatases.

K Roiko1, O A Jänne, P Vihko.   

Abstract

Overlapping cDNA clones encoding rat prostatic acid phosphatase (rPAP) were isolated by using two human prostatic acid phosphatase (hPAP)-encoding cDNAs to screen rat prostatic cDNA libraries. The isolated cDNAs encompassed a total of 1626 nucleotides (nt), of which 1143 nt corresponded to the protein coding sequence encoding a mature polypeptide of 350 amino acids (aa) and a 31-aa long signal peptide-like sequence. The deduced Mr of the mature rPAP was 40,599. RNA blot analysis indicated the presence of three mRNA species (4.9, 2.3 and 1.5 kb in size) in the rat prostate. The deduced aa sequences of rPAP and hPAP show 75% identity, whereas the similarity between rPAP and human lysosomal acid phosphatase (hLAP) is only 45%. Furthermore, the sequence similarity between rPAP and rat lysosomal acid phosphatase (rLAP) is 46% at the aa level. Similar to hPAP, but unlike hLAP and rLAP, the rPAP sequence lacks a membrane-anchoring domain indicating the secretory character of this phosphatase. All six cysteines present in the overlapping areas of the mature rPAP, hPAP, rLAP and hLAP proteins are positionally conserved, suggesting that these residues are important for the tertiary structure of acid phosphatases (APs). The previously reported active site residues, two arginines and one histidine, are also conserved in these APs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373368     DOI: 10.1016/0378-1119(90)90009-g

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  14 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-06-11       Impact factor: 16.971

2.  Cloning and characterization of a cDNA encoding a maize seedling phytase.

Authors:  S Maugenest; I Martinez; A M Lescure
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

3.  Rat acid phosphatase: overexpression of active, secreted enzyme by recombinant baculovirus-infected insect cells, molecular properties, and crystallization.

Authors:  P Vihko; R Kurkela; K Porvari; A Herrala; A Lindfors; Y Lindqvist; G Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

4.  Prostate carcinoma in transgenic Lewis rats - a tumor model for evaluation of immunological treatments.

Authors:  Laura E Johnson; Jordan T Becker; Jason A Dubovsky; Brian M Olson; Douglas G McNeel
Journal:  Chin Clin Oncol       Date:  2013-03-01

5.  DNA Vaccines for Prostate Cancer.

Authors:  Douglas G McNeel; Jordan T Becker; Laura E Johnson; Brian M Olson
Journal:  Curr Cancer Ther Rev       Date:  2012-11-01

6.  Immunocytochemical localization of seminal proteins in salivary and lacrimal glands of the rat.

Authors:  G Aumüller; E A Arce; W Heyns; I Vercaeren; I Dammshäuser; J Seitz
Journal:  Cell Tissue Res       Date:  1995-04       Impact factor: 5.249

Review 7.  Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor.

Authors:  Sakthivel Muniyan; Matthew A Ingersoll; Surinder K Batra; Ming-Fong Lin
Journal:  Biochim Biophys Acta       Date:  2014-04-18

8.  Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosine.

Authors:  Mark J Zylka; Nathaniel A Sowa; Bonnie Taylor-Blake; Margaret A Twomey; Annakaisa Herrala; Vootele Voikar; Pirkko Vihko
Journal:  Neuron       Date:  2008-10-09       Impact factor: 17.173

9.  Recombinant mouse PAP has pH-dependent ectonucleotidase activity and acts through A(1)-adenosine receptors to mediate antinociception.

Authors:  Nathaniel A Sowa; Kunjumon I Vadakkan; Mark J Zylka
Journal:  PLoS One       Date:  2009-01-22       Impact factor: 3.240

10.  Prostatic acid phosphatase is expressed in peptidergic and nonpeptidergic nociceptive neurons of mice and rats.

Authors:  Bonnie Taylor-Blake; Mark J Zylka
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.